Samuel Herschkowitz
Direttore/Membro del Consiglio presso ACERUS PHARMACEUTICALS CORPORATION
Posizioni attive di Samuel Herschkowitz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACERUS PHARMACEUTICALS CORPORATION | Direttore/Membro del Consiglio | - | - |
NYU Langone Health
 NYU Langone Health Packaged SoftwareTechnology Services NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Serenity Pharmaceuticals LLC
 Serenity Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Acerus Pharmaceuticals Corp., Serenity Pharmaceuticals LLC is a company that manufactures and distributes drugs. The company is based in Miami, FL. The company was founded by Samuel Herschkowitz. Samuel Herschkowitz has been the CEO since incorporation. Serenity Pharmaceuticals was acquired by Acerus Pharmaceuticals Corp. on March 07, 2022 for $44.30 million. | Amministratore Delegato | - | - |
| Presidente | - | - | |
| Fondatore | - | - |
Storia della carriera di Samuel Herschkowitz
Precedenti posizioni note di Samuel Herschkowitz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Serenity Pharmaceuticals Corp.
 Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Serenity Pharmaceuticals Corp. develops products pharmaceuticals that address urinary conditions. The company was founded by Samuel Herschkowitz in 2007 and is headquartered in Milford, PA. | Amministratore Delegato | 14/09/2009 | 01/02/2022 |
| Presidente | 01/01/2007 | 01/02/2022 | |
| Fondatore | 01/01/2007 | 01/02/2022 | |
| PROSPECT PARK CAPITAL CORP. | Direttore/Membro del Consiglio | - | 23/01/2020 |
| Amministratore Delegato | - | 23/01/2020 | |
| Direttore Finanziario/CFO | - | 23/10/2014 | |
| DELCATH SYSTEMS, INC. | Direttore/Membro del Consiglio | 01/01/1988 | 17/06/2007 |
| Direttore operativo | 01/01/1988 | 17/06/2007 | |
| Direttore Tecnico/Scientifico/R&S | 01/01/1988 | 17/06/2007 |
Formazione di Samuel Herschkowitz
| Syracuse University | Undergraduate Degree |
| State University of New York at Downstate Medical Center | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Canada | 3 |
Posizioni
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| Chairman | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| DELCATH SYSTEMS, INC. | Health Technology |
| PROSPECT PARK CAPITAL CORP. | Finance |
| Aziende private | 4 |
|---|---|
NYU Langone Health
NYU Langone Health Packaged SoftwareTechnology Services NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY. | Technology Services |
Serenity Pharmaceuticals Corp.
Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Serenity Pharmaceuticals Corp. develops products pharmaceuticals that address urinary conditions. The company was founded by Samuel Herschkowitz in 2007 and is headquartered in Milford, PA. | Health Technology |
Serenity Pharmaceuticals LLC
Serenity Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Acerus Pharmaceuticals Corp., Serenity Pharmaceuticals LLC is a company that manufactures and distributes drugs. The company is based in Miami, FL. The company was founded by Samuel Herschkowitz. Samuel Herschkowitz has been the CEO since incorporation. Serenity Pharmaceuticals was acquired by Acerus Pharmaceuticals Corp. on March 07, 2022 for $44.30 million. | Health Technology |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Samuel Herschkowitz
- Esperienza